Literature DB >> 14769548

Comparison of the pharmacological properties of rat Na(V)1.8 with rat Na(V)1.2a and human Na(V)1.5 voltage-gated sodium channel subtypes using a membrane potential sensitive dye and FLIPR.

R G Vickery1, S M Amagasu, R Chang, N Mai, E Kaufman, J Martin, J Hembrador, M D O'Keefe, C Gee, D Marquess, J A M Smith.   

Abstract

A novel, membrane potential sensitive dye and a fluorescence imaging plate reader (FLIPR) have been used to characterize the pharmacological properties of rat Na(v)1.8 voltage-gated sodium channels (VGSC) in parallel with rat Na(v)1.2a and human Na(v)1.5 VGSC subtypes, respectively. The sensitivity of recombinant Na(v)1.2a-CHO, Na(v)1.5-293-EBNA, and Na(v)1.8-F-11 cells to VGSC activators was subtype dependent. Veratridine evoked depolarization of Na(v)1.2a-CHO and Na(v)1.5-293-EBNA cells with pEC(50) values of 4.78 +/- 0.13 and 4.84 +/- 0.12, respectively (n = 3), but had negligible effect on Na(v)1.8-F-11 cells (pEC(50) < 4.5). Type I pyrethroids were without significant effect at all subtypes. In contrast, the type II pyrethroids deltamethrin and fenvalerate evoked direct depolarization of Na(v)1.8-F-11 and Na(v)1.5-293-EBNA cells. Deltamethrin potentiated the veratridine-evoked response in Na(v)1.8-F-11 cells by > or =20-fold, in contrast to a <or =3-fold potentiation of the response in Na(v)1.2a, and Na(v)1.5 cells. Tetrodotoxin (TTX) inhibited VGSC activator-evoked depolarization of Na(v)1.8-F-11 cells with a biphasic concentration-response curve. The calculated pIC(50) values were 8.05 +/- 0.25 (n = 4) and 4.32 +/- 0.21 (n = 4), corresponding to TTX inhibition of endogenous TTX-sensitive (TTX-S), and recombinant Na(v)1.8 TTX-resistant (TTX-R) VGSCs, respectively. With the exception of TTX, the potencies of a number of ion channel blockers for the Na(v)1.8, Na(v)1.2a, and Na(v)1.5 VGSC subtypes were similar. In summary, these high-throughput FLIPR assays represent a valuable tool for the determination of the relative potencies of compounds at different VGSC subtypes and may prove useful for the identification of novel subtype-selective inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769548

Source DB:  PubMed          Journal:  Receptors Channels        ISSN: 1060-6823


  6 in total

Review 1.  Diverse mechanisms of antiepileptic drugs in the development pipeline.

Authors:  Michael A Rogawski
Journal:  Epilepsy Res       Date:  2006-04-18       Impact factor: 3.045

Review 2.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

3.  A comparison of the effects of veratridine on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in isolated rat dorsal root ganglion neurons.

Authors:  K J Farrag; A Bhattacharjee; R J Docherty
Journal:  Pflugers Arch       Date:  2007-10-26       Impact factor: 3.657

4.  Development of a high-throughput fluorescent no-wash sodium influx assay.

Authors:  Bryan Tay; Teneale A Stewart; Felicity M Davis; Jennifer R Deuis; Irina Vetter
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

5.  Veratridine Can Bind to a Site at the Mouth of the Channel Pore at Human Cardiac Sodium Channel NaV1.5.

Authors:  Alican Gulsevin; Andrew M Glazer; Tiffany Shields; Brett M Kroncke; Dan M Roden; Jens Meiler
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

Review 6.  Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.

Authors:  Edward C Emery; Ana Paula Luiz; John N Wood
Journal:  Expert Opin Ther Targets       Date:  2016-04-12       Impact factor: 6.902

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.